Molecular and clinical aspects of the Neu/ErbB-2 receptor tyrosine kinase

作者: Ilana Stancovski , Michael Sela , Yosef Yarden

DOI: 10.1007/978-1-4615-2592-9_9

关键词: Epidermal growth factor receptorCancer researchBiologyReceptor tyrosine kinaseEpidermal growth factorCell surface receptorGrowth factor receptorSignal transductionErbBPlatelet-derived growth factor receptor

摘要: Tumorigenesis in model experimental systems involves multiple steps that include activation of cell growth and inactivation inhibitory processes [1,2]. Tumor development humans is thought to reflect the multiplicity events accumulation independent mutations affect clonal cancerous [3]. The identity group genes confer malignancy vitro appears be similar set are mutated animal human tumors [4]. All whose products undergo mutational (oncogenes) encode key regulatory elements signal transduction pathways lead [5]. Thus, oncogenic proteins may factors, their membrane receptors, cytoplasmic effector proteins, or nuclear factors control gene expression. In systems, altered forms receptors for can induce tumorigenesis. Examples fms erbB retroviral portions colony stimulating factor 1 (CSF-1) [6] epidermal (EGF) [7], respectively. However, possibility modifications one molecular crucial tumor remains open.

参考文章(216)
T Lam, K L Trimpe, P J Marks, W P Carney, S J McKenzie, J Morgan, D L Panicali, Generation and characterization of monoclonal antibodies specific for the human neu oncogene product, p185. Oncogene. ,vol. 4, pp. 543- 548 ,(1989)
Carlos Cordon-Cardo, Michael F. Press, Dennis J. Slamon, Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene. ,vol. 5, pp. 953- 962 ,(1990)
C. I. Bargmann, R. A. Weinberg, Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion. The EMBO Journal. ,vol. 7, pp. 2043- 2052 ,(1988) , 10.1002/J.1460-2075.1988.TB03044.X
G Sliutz, R Zeillinger, E Kubista, K Czerwenka, R Jakesz, G Reiner, J Huber, F Kury, W Knogler, C Zielinski, HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer. Oncogene. ,vol. 4, pp. 109- 114 ,(1989)
E. Peles, R.B. Levy, E. Or, A. Ullrich, Y. Yarden, Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gamma. The EMBO Journal. ,vol. 10, pp. 2077- 2086 ,(1991) , 10.1002/J.1460-2075.1991.TB07739.X
C. R. King, I. Borrello, F. Bellot, P. Comoglio, J. Schlessinger, Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3. The EMBO Journal. ,vol. 7, pp. 1647- 1651 ,(1988) , 10.1002/J.1460-2075.1988.TB02991.X
Tsioulias Gj, Muto T, Morioka Y, Yamamoto T, Mori S, erbB-2 gene expression in colorectal cancer. The Japanese journal of experimental medicine. ,vol. 60, pp. 343- 349 ,(1990)